Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis

Journal of the American Academy of Dermatology

Volumn 57, Issue 4, 2007, Pages 725-727

  Goveia, Michelle ^a,c   Chan, Benjamin P ^b   Patel, Priti R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GADOLINIUM; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; NEPHROGENIC FIBROSING DERMOPATHY; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; DRUG INTERACTIONS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FIBROSIS; GADOLINIUM; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RISK FACTORS; SKIN; SKIN DISEASES;

EID: 34548543642     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.07.010     Document Type: Article

References (6)

1. High W.A., Ayers R.A., and Cowper S.E. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56 (2007) 710-712
2. Swaminathan S., Ahmed I., McCarthy J.T., Albright R.C., Pittelkow M.R., Caplice N.M., et al. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 145 (2006) 234-235
3. Centers for Disease Control and Prevention. Public health dispatch: fibrosing skin condition among patients with renal disease-United States and Europe, 1997-2002. MMWR Morb Mortal Wkly Rep 51 (2002) 25-26
4. U.S. Renal Data System. USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2006.
5. Haroon Z.A., Amin K., Jiang X., and Arcasoy M.O. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163 (2003) 993-1000
6. Centers for Disease Control and Prevention. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents-St Louis, Missouri, 2002-2006. MMWR Morb Mortal Wkly Rep 56 (2007) 137-141